Cell-type-specific tyrosine phosphorylation of the herpes simplex virus tegument protein VP11/12 encoded by gene UL46

Journal of Virology

Volumn 82, Issue 13, 2008, Pages 6098-6108

  Zahariadis, George ^a,b,c   Wagner, Melany J ^a   Doepker, Rosalyn C ^a   Maciejko, Jessica M ^a   Crider, Carly M ^d   Jerome, Keith R ^d   Smiley, James R ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; T LYMPHOCYTE RECEPTOR; VIRUS PROTEIN; VP 11/12 PROTEIN;

ARTICLE; B LYMPHOCYTE; CELL TYPE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FIBROBLAST; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; MASS SPECTROMETRY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SOUTHERN BLOTTING; UL46 GENE; VIRUS GENE; WESTERN BLOTTING;

ANTIGENS, VIRAL; BLOTTING, SOUTHERN; BLOTTING, WESTERN; DNA PRIMERS; HUMANS; JURKAT CELLS; KILLER CELLS, NATURAL; MASS SPECTROMETRY; PHOSPHORYLATION; PLASMIDS; SIGNAL TRANSDUCTION; TYROSINE; VIRAL PROTEINS;

HERPESVIRIDAE; SIMPLEXVIRUS;

EID: 45749138428     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02121-07     Document Type: Article

References (60)

1. Ambagala, A. P., J. C. Solheim, and S. Srikumaran. 2005. Viral interference with MHC class I antigen presentation pathway: the battle continues. Vet. Immunol. Immunopathol. 107:1-15.
2. Arnon, T. I., G. Markel, and O. Mandelboim. 2006. Tumor and viral recognition by natural killer cells receptors. Semin. Cancer Biol. 16:348-358.
3. Aubert, M., E. M. Krantz, and K. R. Jerome. 2006. Herpes simplex virus genes Us3, Us5, and Us12 differentially regulate cytotoxic T lymphocyte-induced cytotoxicity. Viral Immunol. 19:391-408.
4. Benedict, C. A., P. S. Norris, and C. F. Ware. 2002. To kill or be killed: viral evasion of apoptosis. Nat. Immunol. 3:1013-1018.
5. Blaho, J. A., C. S. Zong, and K. A. Mortimer. 1997. Tyrosine phosphorylation of the herpes simplex virus type 1 regulatory protein ICP22 and a cellular protein which shares antigenic determinants with ICP22. J. Virol. 71:9828-9832.
6. Branco, F. J., and N. W. Fraser. 2005. Herpes simplex virus type 1 latency-associated transcript expression protects trigeminal ganglion neurons from apoptosis. J. Virol. 79:9019-9025.
7. Cartier, A., E. Broberg, T. Komai, M. Henriksson, and M. G. Masucci. 2003. The herpes simplex virus-1 Us3 protein kinase blocks CD8 T cell lysis by preventing the cleavage of Bid by granzyme B. Cell Death Differ. 10:1320-1328.
8. Confer, D. L., G. M. Vercellotti, D. Kotasek, J. L. Goodman, A. Ochoa, and H. S. Jacob. 1990. Herpes simplex virus-infected cells disarm killer lymphocytes. Proc. Natl. Acad. Sci. USA 87:3609-3613.
9. Court, D. L., J. A. Sawitzke, and L. C. Thomason. 2002. Genetic engineering using homologous recombination. Annu. Rev. Genet. 36:361-388.
10. Dargan, D. J., A. H. Patel, and J. H. Subak-Sharpe. 1995. PREPs: herpes simplex virus type 1-specific particles produced by infected cells when viral DNA replication is blocked. J. Virol. 69:4924-4932.
11. + T cells maintain HSV-1 latency. Immunol. Res. 36:119-126.
12. Ertl, H. C. J. 2003. Viral immunology, p. 1201-1228. In W. E. Paul (ed.), Fundamental immunology, 5th ed. Lippincott, Williams & Wilkins, New York, NY.
13. Gierasch, W. W., D. L. Zimmerman, S. L. Ward, T. K. Vanheyningen, J. D. Romine, and D. A. Leib. 2006. Construction and characterization of bacterial artificial chromosomes containing HSV-1 strains 17 and KOS. J. Virol. Methods 135:197-206.
14. Goldsmith, M. A., and A. Weiss. 1987. Isolation and characterization of a T-lymphocyte somatic mutant with altered signal transduction by the antigen receptor. Proc. Natl. Acad. Sci. USA 84:6879-6883.
15. Gupta, A., J. J. Gartner, P. Sethupathy, A. G. Hatzigeorgiou, and N. W. Fraser. 2006. Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442:82-85.
16. Han, J. Y., D. D. Sloan, M. Aubert, S. A. Miller, C. H. Dang, and K. R. Jerome. 2007. Apoptosis and antigen receptor function in T and B cells following exposure to herpes simplex virus. Virology 359:253-263.
17. Hill, A., P. Jugovic, I. York, G. Russ, J. Bennink, J. Yewdell, H. Ploegh, and D. Johnson. 1995. Herpes simplex virus turns off the TAP to evade host immunity. Nature 375:411-415.
18. Hui, C. K., and G. K. Lau. 2005. Immune system and hepatitis B virus infection. J. Clin. Virol. 34(Suppl. 1):S44-S48.
19. Jerome, K. R., R. Fox, Z. Chen, A. E. Sears, H. Lee, and L. Corey. 1999. Herpes simplex virus inhibits apoptosis through the action of two genes, Us5 and Us3. J. Virol. 73:8950-8957.
20. Jerome, K. R., J. F. Tait, D. M. Koelle, and L. Corey. 1998. Herpes simplex virus type 1 renders infected cells resistant to cytotoxic T-lymphocyte-induced apoptosis. J. Virol. 72:436-441.
21. Jugovic, P., A. M. Hill, R. Tomazin, H. Ploegh, and D. C. Johnson. 1998. Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47. J. Virol. 72:5076-5084.
22. Kato, K., T. Daikoku, F. Goshima, H. Kume, K. Yamaki, and Y. Nishiyama. 2000. Synthesis, subcellular localization and VP16 interaction of the herpes simplex virus type 2 UL46 gene product. Arch. Virol. 145:2149-2162.
23. Kavathas, P., F. H. Bach, and R. DeMars. 1980. Gamma ray-induced loss of expression of HLA and glyoxalase I alleles in lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 77:4251-4255.
24. Klenerman, P., and A. Hill. 2005. T cells and viral persistence: lessons from diverse infections. Nat. Immunol. 6:873-879.
25. Lemaster, S., and B. Roizman. 1980. Herpes simplex virus phosphoproteins. II. Characterization of the virion protein kinase and of the polypeptides phosphorylated in the virion. J. Virol. 35:798-811.
26. Leopardi, R., C. Van Sant, and B. Roizman. 1997. The herpes simplex virus 1 protein kinase US3 is required for protection from apoptosis induced by the virus. Proc. Natl. Acad. Sci. USA 94:7891-7896.
27. Levy, J. A. 2006. HIV pathogenesis: knowledge gained after two decades of research. Adv. Dent. Res. 19:10-16.
28. Liang, Y., and B. Roizman. 2006. State and role of SRC family kinases in replication of herpes simplex virus 2. J. Virol. 80:3349-3359.
29. Matsuzaki, A., Y. Yamauchi, A. Kato, F. Goshima, Y. Kawaguchi, T. Yoshikawa, and Y. Nishiyama. 2005. US3 protein kinase of herpes simplex virus type 2 is required for the stability of the UL46-encoded tegument protein and its association with virus particles. J. Gen. Virol. 86:1979-1985.
30. McKnight, J. L., P. E. Pellett, F. J. Jenkins, and B. Roizman. 1987. Characterization and nucleotide sequence of two herpes simplex virus 1 genes whose products modulate α-trans-inducing factor-dependent activation of α genes. J. Virol. 61:992-1001.
31. Minaker, R. L., K. L. Mossman, and J. R. Smiley. 2005. Functional inaccessibility of quiescent herpes simplex virus genomes. Virol. J. 2:85.
32. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197-223.
33. Morrison, E. E., Y. F. Wang, and D. M. Meredith. 1998. Phosphorylation of structural components promotes dissociation of the herpes simplex virus type 1 tegument. J. Virol. 72:7108-7114.
34. Omri, B., P. Crisanti, M. C. Marty, F. Alliot, R. Fagard, T. Molina, and B. Pessac. 1996. The Lck tyrosine kinase is expressed in brain neurons. J. Neurochem. 67:1360-1364.
35. Orange, J. S. 2002. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 4:1545-1558.
36. Palacios, E. H., and A. Weiss. 2004. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 23:7990-8000.
37. Perlmutter, R. M., J. D. Marth, D. B. Lewis, R. Peet, S. F. Ziegler, and C. B. Wilson. 1988. Structure and expression of lck transcripts in human lymphoid cells. J. Cell. Biochem. 38:117-126.
38. Posavad, C. M., J. J. Newton, and K. L. Rosenthal. 1994. Infection and inhibition of human cytotoxic T lymphocytes by herpes simplex virus. J. Virol. 68:4072-4074.
39. Posavad, C. M., J. J. Newton, and K. L. Rosenthal. 1993. Inhibition of human CTL-mediated lysis by fibroblasts infected with herpes simplex virus. J. Immunol. 151:4865-4873.
40. Posavad, C. M., and K. L. Rosenthal. 1992. Herpes simplex virus-infected human fibroblasts are resistant to and inhibit cytotoxic T-lymphocyte activity. J. Virol. 66:6264-6272.
41. Shiina, M., and B. Rehermann. 2006. Hepatitis C vaccines: inducing and challenging memory T cells. Hepatology 43:1395-1398.
42. Sloan, D. D., J. Y. Han, T. K. Sandifer, M. Stewart, A. J. Hinz, M. Yoon, D. C. Johnson, P. G. Spear, and K. R. Jerome. 2006. Inhibition of TCR signaling by herpes simplex virus. J. Immunol. 176:1825-1833.
43. Sloan, D. D., and K. R. Jerome. 2007. Herpes simplex virus remodels T cell receptor signaling resulting in p38-dependent selective synthesis of interleukin-10. J. Virol. 81:12504-12514.
44. Sloan, D. D., G. Zahariadis, C. M. Posavad, N. T. Pate, S. J. Kussick, and K. R. Jerome. 2003. CTL are inactivated by herpes simplex virus-infected cells expressing a viral protein kinase. J. Immunol. 171:6733-6741.
45. Stevely, W. S., M. Katan, V. Stirling, G. Smith, and D. P. Leader. 1985. Protein kinase activities associated with the virions of pseudorabies and herpes simplex virus. J. Gen. Virol. 66:661-673.
46. + T cells in individuals with HIV infection: correlation with protection from CMV disease. J. Antimicrob. Chemother. 57:585-588.
47. Straus, D. B., and A. Weiss. 1992. Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70:585-593.
48. Szilágyi, J. F., and J. Berriman. 1994. Herpes simplex virus L particles contain spherical membrane-enclosed inclusion vesicles. J. Gen. Virol. 75:1749-1753.
49. + CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-γ or when virion host shutoff functions are disabled. J. Immunol. 156:3901-3910.
50. lck protooncogene in rat cerebellar granular neurons. J. Neurochem. 67:2306-2315.
51. Vittone, V., E. Diefenbach, D. Triffett, M. W. Douglas, A. L. Cunningham, and R. J. Diefenbach. 2005. Determination of interactions between tegument proteins of herpes simplex virus type 1. J. Virol. 79:9566-9571.
52. Warming, S., N. Costantino, D. L. Court, N. A. Jenkins, and N. G. Copeland. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33:e36.
53. Willard, M. 2002. Rapid directional translocations in virus replication. J. Virol. 76:5220-5232.
54. Wonderlich, J., G. Shearer, A. Livingstone, and A. Brooks. 2006. Induction and measurement of cytotoxic T lymphocyte activity, p. 3.11.1-3.11.23. In J. E. Coligan, B. E. Bierer, D. H. Margulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology. John Wiley & Sons Inc., New York, NY.
55. Wysocka, J., and W. Herr. 2003. The herpes simplex virus VP16-induced complex: the makings of a regulatory switch. Trends Biochem. Sci. 28:294-304.
56. Xu, Y., K. W. Harder, N. D. Huntington, M. L. Hibbs, and D. M. Tarlinton. 2005. Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 22:9-18.
57. - T lymphocytes. Cell 77:525-535.
58. York, I. A., and D. C. Johnson. 1993. Direct contact with herpes simplex virus-infected cells results in inhibition of lymphokine-activated killer cells because of cell-to-cell spread of virus. J. Infect. Dis. 168:1127-1132.
59. Zhang, Y., and J. L. McKnight. 1993. Herpes simplex virus type 1 UL46 and UL47 deletion mutants lack VP11 and VP12 or VP13 and VP14, respectively, and exhibit altered viral thymidine kinase expression. J. Virol. 67:1482-1492.
60. Zhang, Y., D. A. Sirko, and J. L. McKnight. 1991. Role of herpes simplex virus type 1 UL46 and UL47 in αTIF-mediated transcriptional induction: characterization of three viral deletion mutants. J. Virol. 65:829-841.